Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Vaccines01:30

Cancer Vaccines

1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Translated article] New Insights on the Etiopathogenesis of Vitiligo.

Actas dermo-sifiliograficas·2025
Same author

New Insights on the Etiopathogenesis of Vitiligo.

Actas dermo-sifiliograficas·2025
Same author

Quantitative analysis of Tr1 lymphocytes in patients with type 2 diabetes mellitus.

Journal of endocrinological investigation·2024
Same author

Nanoparticles Stokes radius assessment through permeability coefficient determination within a new stratified epithelium on-chip model.

Artificial cells, nanomedicine, and biotechnology·2023
Same author

Comprehensive micropollutant characterization of wastewater during Covid-19 crisis in 2020: Suspect screening and environmental risk prioritization strategy.

The Science of the total environment·2023
Same author

Analyzing the potential environmental impact of NIOSH list of hazardous drugs (group 2).

The Science of the total environment·2023

Related Experiment Video

Updated: Mar 13, 2026

Encapsulation Thermogenic Preadipocytes for Transplantation into Adipose Tissue Depots
08:30

Encapsulation Thermogenic Preadipocytes for Transplantation into Adipose Tissue Depots

Published on: June 2, 2015

9.9K

Microencapsulated Cells for Cancer Therapy.

L Saenz del Burgo1,2, J Ciriza1,2, R M Hernández1,2

  • 1NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, 01006, Vitoria-Gasteiz, Spain.

Methods in Molecular Biology (Clifton, N.J.)
|October 15, 2016
PubMed
Summary

Microencapsulation of hybridoma cells in alginate-poly-L-lysine-alginate beads offers a novel cancer therapy. This method enables sustained, in-situ production of therapeutic antibodies to enhance anti-tumor immune responses.

Keywords:
AlginateCancerCell microencapsulationControlled drug delivery systemElectrostatic bead generatorHybridoma cellsMicrotechnology

More Related Videos

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye
06:10

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Published on: March 30, 2020

8.4K
Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

15.7K

Related Experiment Videos

Last Updated: Mar 13, 2026

Encapsulation Thermogenic Preadipocytes for Transplantation into Adipose Tissue Depots
08:30

Encapsulation Thermogenic Preadipocytes for Transplantation into Adipose Tissue Depots

Published on: June 2, 2015

9.9K
Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye
06:10

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Published on: March 30, 2020

8.4K
Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

15.7K

Area of Science:

  • Biotechnology
  • Oncology
  • Materials Science

Background:

  • Cell microencapsulation offers a promising alternative to repeated parenteral treatments for chronic diseases.
  • This approach is being explored in oncology for sustained, in-situ production of therapeutic antibodies to boost anti-tumor immunity.

Purpose of the Study:

  • To detail the fabrication of alginate-poly-L-lysine-alginate microcapsules containing hybridoma cells for cancer management.
  • To outline methods for evaluating the long-term viability of encapsulated cells.

Main Methods:

  • Utilized an electrostatic bead generator for fabricating alginate-poly-L-lysine-alginate microcapsules.
  • Incorporated hybridoma cells within the microcapsules for therapeutic antibody production.
  • Developed protocols for assessing cell viability over time post-encapsulation.

Main Results:

  • Successfully fabricated alginate-poly-L-lysine-alginate microcapsules containing hybridoma cells.
  • Established methods for evaluating the viability of encapsulated hybridoma cells over extended periods.
  • Demonstrated the potential for in-situ, sustained therapeutic factor delivery.

Conclusions:

  • Alginate-poly-L-lysine-alginate microencapsulation is a viable method for cancer therapy delivery systems.
  • This technique allows for comfortable, sustained, and localized delivery of therapeutic agents.
  • Further research can optimize this approach for enhanced cancer treatment strategies.